Main Management ETF Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Main Management ETF Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$944K	Buy
2025 Q3	$1.16M	Sell
2025 Q2	$963K	Buy
2025 Q1	$662K	Buy
2024 Q4	$532K	Sell
2024 Q3	$693K	Buy